OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Serological response following BNT162b2 anti‐SARS‐CoV‐2 mRNA vaccination in haematopoietic stem cell transplantation patients
Immacolata Attolico, Francesco Tarantini, Paola Carluccio, et al.
British Journal of Haematology (2021) Vol. 196, Iss. 4, pp. 928-931
Open Access | Times Cited: 23
Immacolata Attolico, Francesco Tarantini, Paola Carluccio, et al.
British Journal of Haematology (2021) Vol. 196, Iss. 4, pp. 928-931
Open Access | Times Cited: 23
Showing 23 citing articles:
COVID-19 Infection in Children and Infants: Current Status on Therapies and Vaccines
Giuseppina Malcangi, Alessio Danilo Inchingolo, Angelo Michele Inchingolo, et al.
Children (2022) Vol. 9, Iss. 2, pp. 249-249
Open Access | Times Cited: 42
Giuseppina Malcangi, Alessio Danilo Inchingolo, Angelo Michele Inchingolo, et al.
Children (2022) Vol. 9, Iss. 2, pp. 249-249
Open Access | Times Cited: 42
Spike-Specific Memory B Cell Response in Hematopoietic Cell Transplantation Recipients following Multiple mRNA-1273 Vaccinations: A Longitudinal Observational Study
Elena Pettini, Annalisa Ciabattini, Fabio Fiorino, et al.
Vaccines (2024) Vol. 12, Iss. 4, pp. 368-368
Open Access | Times Cited: 4
Elena Pettini, Annalisa Ciabattini, Fabio Fiorino, et al.
Vaccines (2024) Vol. 12, Iss. 4, pp. 368-368
Open Access | Times Cited: 4
The Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Japanese Patients after Allogeneic Stem Cell Transplantation
Marika Watanabe, Kimikazu Yakushijin, Yohei Funakoshi, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 158-158
Open Access | Times Cited: 17
Marika Watanabe, Kimikazu Yakushijin, Yohei Funakoshi, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 158-158
Open Access | Times Cited: 17
Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis
Noppacharn Uaprasert, Palada Pitakkitnukun, Nuanrat Tangcheewinsirikul, et al.
Blood Cancer Journal (2022) Vol. 12, Iss. 12
Open Access | Times Cited: 17
Noppacharn Uaprasert, Palada Pitakkitnukun, Nuanrat Tangcheewinsirikul, et al.
Blood Cancer Journal (2022) Vol. 12, Iss. 12
Open Access | Times Cited: 17
COVID‐19 after hematopoietic cell transplantation and chimeric antigen receptor (CAR)‐T‐cell therapy
Eleftheria Kampouri, Joshua A. Hill, M. Veronica Dioverti
Transplant Infectious Disease (2023) Vol. 25, Iss. S1
Closed Access | Times Cited: 10
Eleftheria Kampouri, Joshua A. Hill, M. Veronica Dioverti
Transplant Infectious Disease (2023) Vol. 25, Iss. S1
Closed Access | Times Cited: 10
Survival in multiple myeloma and SARS‐COV‐2 infection through the COVID‐19 pandemic: Results from the EPICOVIDEHA registry
Pellegrino Musto, Jon Salmanton‐García, Nicola Sgherza, et al.
Hematological Oncology (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 10
Pellegrino Musto, Jon Salmanton‐García, Nicola Sgherza, et al.
Hematological Oncology (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 10
A Third Dose COVID-19 Vaccination in Allogeneic Hematopoietic Stem Cell Transplantation Patients
Marika Watanabe, Kimikazu Yakushijin, Yohei Funakoshi, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1830-1830
Open Access | Times Cited: 16
Marika Watanabe, Kimikazu Yakushijin, Yohei Funakoshi, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1830-1830
Open Access | Times Cited: 16
Effectiveness of SARS-CoV-2 Vaccines for Short- and Long-Term Immunity: A General Overview for the Pandemic Contrast
Alessio Danilo Inchingolo, Giuseppina Malcangi, Sabino Ceci, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8485-8485
Open Access | Times Cited: 15
Alessio Danilo Inchingolo, Giuseppina Malcangi, Sabino Ceci, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8485-8485
Open Access | Times Cited: 15
Antibody response to COVID-19 vaccine in 130 recipients of hematopoietic stem cell transplantation
Takafumi Tsushima, Toshiki Terao, Kentaro Narita, et al.
International Journal of Hematology (2022) Vol. 115, Iss. 5, pp. 611-615
Open Access | Times Cited: 14
Takafumi Tsushima, Toshiki Terao, Kentaro Narita, et al.
International Journal of Hematology (2022) Vol. 115, Iss. 5, pp. 611-615
Open Access | Times Cited: 14
Diagnosis of SARS-CoV-2 during the Pandemic by Multiplex RT-rPCR hCoV Test: Future Perspectives
Alessio Danilo Inchingolo, Ciro Isacco Gargiulo, Giuseppina Malcangi, et al.
Pathogens (2022) Vol. 11, Iss. 11, pp. 1378-1378
Open Access | Times Cited: 14
Alessio Danilo Inchingolo, Ciro Isacco Gargiulo, Giuseppina Malcangi, et al.
Pathogens (2022) Vol. 11, Iss. 11, pp. 1378-1378
Open Access | Times Cited: 14
SARS-CoV-2 vaccine safety and immunogenicity in patients with hematologic malignancies, transplantation, and cellular therapies
Bin Ni, Ahmad Yanis, Kevin Dee, et al.
Blood Reviews (2022) Vol. 56, pp. 100984-100984
Open Access | Times Cited: 12
Bin Ni, Ahmad Yanis, Kevin Dee, et al.
Blood Reviews (2022) Vol. 56, pp. 100984-100984
Open Access | Times Cited: 12
Vaccine Responses in Adult Hematopoietic Stem Cell Transplant Recipients: A Comprehensive Review
Michelle Janssen, Anke H. W. Bruns, Jürgen Kuball, et al.
Cancers (2021) Vol. 13, Iss. 23, pp. 6140-6140
Open Access | Times Cited: 11
Michelle Janssen, Anke H. W. Bruns, Jürgen Kuball, et al.
Cancers (2021) Vol. 13, Iss. 23, pp. 6140-6140
Open Access | Times Cited: 11
Attenuated immunogenicity of SARS-CoV-2 vaccines and risk factors in stem cell transplant recipients: a meta-analysis
Tanaporn Meejun, Karan Srisurapanont, Kasama Manothummetha, et al.
Blood Advances (2023) Vol. 7, Iss. 18, pp. 5624-5636
Open Access | Times Cited: 4
Tanaporn Meejun, Karan Srisurapanont, Kasama Manothummetha, et al.
Blood Advances (2023) Vol. 7, Iss. 18, pp. 5624-5636
Open Access | Times Cited: 4
Homologous versus Heterologous prime-boost COVID-19 Vaccination in autologous hematopoietic stem cell transplantation recipients: a blinded randomized controlled trial
Leyla Sharifi Aliabadi, Manoochehr Karami, Maryam Barkhordar, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Leyla Sharifi Aliabadi, Manoochehr Karami, Maryam Barkhordar, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Cellular and humoral immunogenicity against SARS-CoV-2 vaccination or infection is associated with the memory phenotype of T- and B-lymphocytes in adult allogeneic hematopoietic cell transplant recipients
Takaaki Konuma, Megumi Hamatani-Asakura, Etsuko Nagai, et al.
International Journal of Hematology (2024) Vol. 120, Iss. 2, pp. 229-240
Open Access | Times Cited: 1
Takaaki Konuma, Megumi Hamatani-Asakura, Etsuko Nagai, et al.
International Journal of Hematology (2024) Vol. 120, Iss. 2, pp. 229-240
Open Access | Times Cited: 1
Evaluation of Safety and Immunogenicity of a Recombinant Receptor-Binding Domain (RBD)-Tetanus Toxoid (TT) Conjugated SARS-CoV-2 Vaccine (PastoCovac) in Recipients of Autologous Hematopoietic Stem Cell Transplantation Compared to the Healthy Controls; A Prospective, Open-Label Clinical Trial
Maryam Barkhordar, Mohammad Ahmadvand, Leyla Sharifi Aliabadi, et al.
Vaccines (2023) Vol. 11, Iss. 1, pp. 117-117
Open Access | Times Cited: 2
Maryam Barkhordar, Mohammad Ahmadvand, Leyla Sharifi Aliabadi, et al.
Vaccines (2023) Vol. 11, Iss. 1, pp. 117-117
Open Access | Times Cited: 2
Lessons learned from COVID-19 pandemic: outcomes after SARS-CoV-2 infection in hematopoietic cell transplant and cell therapy recipients
Joe S. Al-Ramahi, Moazzam Shahzad, Kevin Li, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2023) Vol. 64, Iss. 12, pp. 1981-1991
Closed Access | Times Cited: 2
Joe S. Al-Ramahi, Moazzam Shahzad, Kevin Li, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2023) Vol. 64, Iss. 12, pp. 1981-1991
Closed Access | Times Cited: 2
Safety and immunogenicity of BNT162b2 mRNA COVID-19 vaccine in Japanese patients after allogeneic stem cell transplantation
Marika Watanabe, Kimikazu Yakushijin, Yohei Funakoshi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 4
Marika Watanabe, Kimikazu Yakushijin, Yohei Funakoshi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 4
Serological response following anti-SARS-CoV-2 vaccination in hematopoietic stem cell transplantation patients depends upon time from transplant, type of transplant and “booster” dose
Immacolata Attolico, Francesco Tarantini, Paola Carluccio, et al.
Haematologica (2022) Vol. 107, Iss. 5, pp. 1218-1218
Open Access | Times Cited: 3
Immacolata Attolico, Francesco Tarantini, Paola Carluccio, et al.
Haematologica (2022) Vol. 107, Iss. 5, pp. 1218-1218
Open Access | Times Cited: 3
A Third Dose COVID-19 Vaccination in Allogeneic Hematopoietic Stem Cell Transplantation Patients
Marika Watanabe, Kimikazu Yakushijin, Yohei Funakoshi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3
Marika Watanabe, Kimikazu Yakushijin, Yohei Funakoshi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3
Monitoring Humoral Response Following BNT162b2 mRNA Vaccination against SARS-CoV-2 in Hematopoietic Stem-Cell Transplantation Patients: A Single-Center Prospective Study along with a Brief Review of Current Literature
John Asimakopoulos, Eleni Lalou, George Seferlis, et al.
Hematology Reports (2024) Vol. 16, Iss. 2, pp. 220-233
Open Access
John Asimakopoulos, Eleni Lalou, George Seferlis, et al.
Hematology Reports (2024) Vol. 16, Iss. 2, pp. 220-233
Open Access
SARS-CoV-2 infection in fully vaccinated patients with multiple myeloma
Nicola Sgherza, Paola Curci, Rita Rizzi, et al.
Blood Cancer Journal (2021) Vol. 11, Iss. 12
Open Access | Times Cited: 3
Nicola Sgherza, Paola Curci, Rita Rizzi, et al.
Blood Cancer Journal (2021) Vol. 11, Iss. 12
Open Access | Times Cited: 3
Signs and symptoms commonly seen in COVID-19 in newborns, children, and adolescents and pediatric subjects
Giuseppina Malcangi, Alessio Danilo Inchingolo, Angelo Michele Inchingolo, et al.
Elsevier eBooks (2023), pp. 41-59
Closed Access
Giuseppina Malcangi, Alessio Danilo Inchingolo, Angelo Michele Inchingolo, et al.
Elsevier eBooks (2023), pp. 41-59
Closed Access
